← Back to Search

Personal Risk Messaging for COVID-19

N/A
Waitlist Available
Led By Jason Doctor, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will help identify active and recovered infections of SARS-CoV-2 in disadvantaged communities, as well as understand social and behavioral determinants of COVID-19 testing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attendance rate at Time 2 SARS-CoV-2 antibody test
Secondary outcome measures
Social and behavioral determinants of antibody testing

Trial Design

4Treatment groups
Experimental Treatment
Group I: Personal Risk + Lottery IncentiveExperimental Treatment2 Interventions
Personal Risk + Lottery Incentive
Group II: Personal Risk + Loss ProtectionExperimental Treatment2 Interventions
Personal Risk + Loss Protection
Group III: Family Risk + Lottery IncentiveExperimental Treatment2 Interventions
Family Risk + Lottery Incentive
Group IV: Family Risk + Loss ProtectionExperimental Treatment2 Interventions
Family Risk + Loss Protection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lottery Incentive
2021
N/A
~2170
Family Risk Messaging
2021
N/A
~2170
Personal Risk Messaging
2021
N/A
~2170
Loss Protection
2021
N/A
~2170

Find a Location

Who is running the clinical trial?

AltaMed Health ServicesOTHER
7 Previous Clinical Trials
29,040 Total Patients Enrolled
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,594,157 Total Patients Enrolled
7 Trials studying COVID-19
8,859 Patients Enrolled for COVID-19
AltaMed Health Services CorporationOTHER
8 Previous Clinical Trials
29,340 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity for people to be included in this experiment?

"The data located on clinicaltrials.gov indicates that this trial, first made available on June 29th 2021 and last edited July 12th 2022, is not currently searching for new participants. Nevertheless, there are 1022 other medical studies actively recruiting patients at the moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities
Jason Doctor 2021. "Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04901624.
~576 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top